title: [Behçet's disease].
authors.affiliation: Abteilung Innere Medizin II, Medizinische Klinik und Poliklinik der Universität, Tübingen.
authors.forename: I
authors.initials: I
authors.lastname: Kötter
authors.forename: H
authors.initials: H
authors.lastname: Dürk
authors.forename: J G
authors.initials: JG
authors.lastname: Saal
authors.forename: A
authors.initials: A
authors.lastname: Eckstein
authors.forename: M
authors.initials: M
authors.lastname: Zierhut
authors.forename: G
authors.initials: G
authors.lastname: Fierlbeck
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D001528:Behcet Syndrome / Q000175:diagnosis / Q000628:therapy; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D010956:Plasmapheresis; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine